Lactobacillus johnsonii La1 antagonizes Giardia intestinalis in vivo by Humen, Martín Andrés et al.
Vol. 73, No. 2Infection and Immunity, Feb. 2005, p. 1265-1269 
0019-9567/05/$08.00+0 doi:10.1128/IAI.73.2.1265-1269.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Lactobacillus johnsonii Lal Antagonizes Giardia intestinalis In Vivo
Martín A. Humen,1 Graciela L. De Antoni,1,2 Jalil Benyacoub,3 María E. Costas,4
Marta I. Cardozo,4 Leonora Kozubsky,4 Kim-Yen Saudan,3 
Angele Boenzli-Bruand,3 Stephanie Blum,3 
Eduardo J. Schiffrin,3 and Pablo F. Pérez1,2*
* Corresponding author. Mailing address: CIDCA, Universidad Na­
cional de La Plata, Calle 47 y 116 (CC 553), 1900 La Plata, Argentina. 
Phone: 54 221 424 92 87. Fax: 54 221 425 48 53. E-mail: pfp@nahuel 
.biol.unlp.edu.ar.
Centro de Investigación y Desarrollo en Criotecnología de Alimentos,1 and Cátedra de Microbiología2 and Cátedra de 
Parasitología,'1 Departamento de Ciencias Biológicas, Facultad de Ciencias Exactas, Universidad Nacional de 
La Plata, La Plata, Argentina, and Nestlé Research Center, Vers-Chez-les-Blanc,
Lausanne, Switzerland2,
Received 23 August 2004/Returned for modification 16 September 2004/Accepted 18 October 2004
This study describes the in vivo activity of Lactobacillus johnsonii Lal (NCC533) in Giardia intestinalis- 
infected gerbils (Meriones unguiculalus). Daily administration of lactobacilli in the drinking water from 7 days 
before inoculation with Giardia trophozoites efficiently prevented G. intestinalis strain WB clone C6 from 
infecting gerbils. More specifically, shedding of fecal Giardia antigens (GSA65 protein) was diminished in the 
Lal-treated group, and resolution of infection was observed by 21 days postinoculation. Histology and analysis 
of enzymatic markers of microvillus membrane integrity revealed that probiotic administration also protected 
against parasite-induced mucosal damage. In addition, a cellular response to Giardia antigens was stimulated 
in spleen cells from Lal-treated gerbils. Results show for the first time the antigiardial effect of probiotic 
lactobacilli in vivo and provide further insight into the antagonistic properties of lactic acid bacteria against 
protozoa involved in intestinal infections.
Giardia intestinalis, a flagellated protozoan, is the etiological 
agent of giardiasis, an intestinal infection which causes diar­
rhea and malabsorption in humans and animals (19, 22). This 
parasite has a biphasic developmental cycle with two morpho­
logically different forms: cysts and trophozoites. The latter is 
the vegetative form of the parasite which is responsible for 
infection and pathological manifestations (19). Infection fol­
lows the ingestion of cysts which then give rise to trophozoites 
after passage through the stomach and the upper intestinal 
tract.
Giardia is generally treated with antibiotics (e.g., nitroimid­
azoles and nitrofurans). However, clinical failures, occurrence 
of resistant strains, and side effects of wAi-Giardia drugs (21, 
26, 30, 44) have encouraged research on alternative therapeu­
tic strategies which have included the use of plant extracts and 
products derived from bees (12, 21, 25). However, since pro­
biotic microorganisms provide health benefits to the host by 
antagonizing pathogens and modulating both innate and ac­
quired immunity at local and systemic levels (13, 23,24, 33, 40), 
we wondered if such organisms could also be used in the 
treatment of parasitic infections. Certainly, colonization of the 
intestine by Giardia strongly depends on the intestinal micro­
flora (43). Furthermore, in vitro studies show that some pro­
biotic lactobacilli (e.g.,Lactobacillus johnsonii Lal) are able to 
interfere with the cell cycle of G. intestinalis (36). However, 
since this antigiardial effect does not seem to be a general 
property of lactobacilli, further research is required to select 
probiotic strains which can be used in the prevention and 
treatment of such an infection. For this reason, we used an in 
vivo model of giardiasis (Meriones unguiculatus) to gain further 
insight into the antigiardial properties of L. johnsonii Lal 
(NCC533; Nestec Culture Collection). The protocol was ap­
proved by the Nestlé Research Center and state ethical com­
mittees.
Frozen suspensions of L. johnsonii (hereafter Lal) were 
thawed and reactivated in MRS broth before the study. The 
bacteria were then subcultured in MRS broth for 16 h at 37°C 
and harvested by centrifugation at 10,000 x g for 10 min. 
Concentrated suspensions were frozen at —80°C with 10% 
(vol/vol) glycerol until required. After thawing, bacterial 
counts were determined by plating serial dilutions on MRS 
agar.
Trophozoites of clone C6 of the strain WB of G. intestinalis, 
kindly provided by Hugo Luján, University of Córdoba, Cór­
doba, Argentina, were grown in Keister’s modified TYI-S-33 
medium (28) as previously described (36) and then frozen in 
liquid nitrogen until required.
Suspensions of Lal were prepared daily by diluting thawed 
concentrated suspensions in mineral water. Young adult Mon­
golian gerbils (Meriones unguiculatus) ingested bacterial sus­
pensions ad libitum in their drinking water each day beginning 
7 days prior to inoculation with Giardia trophozoites. Based on 
the daily water intake and the bacterial concentration in drink­
ing water, the daily bacterial intake was estimated to be 10s 
CFU per animal. Control animals received mineral water in­
stead of the bacterial suspensions throughout the course of the 
study. Seven days after probiotic treatment had begun, frozen 
trophozoites were thawed in a water bath at 37°C, and a vol­
ume of 200 p.1 (5 x 105 trophozoites) was administered by 
gavage to each animal in the two treatment groups. At various 
time points thereafter, animals were killed by cervical disloca­
tion, and the duodenal contents were analyzed for the presence 
of trophozoites. To this end, 5-cm-long segments of the small 
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intestine were excised at a distance of 11 cm from the pylorus. 
These samples were then placed in 2 ml of ice-cold culture 
medium, opened longitudinally, and vortexed. Enumeration of 
trophozoites was done by using a hemocytometer with a de­
tection limit of 800 trophozoites/cm.
In order to determine fecal giardial antigens, five fecal pel­
lets (0.27 [±0.05] g [wet weight]) per gerbil were homogenized 
in 0.5 ml of extraction buffer (50 mM EDTA, 100 |j.g of soy­
bean trypsin inhibitor [Sigma, St. Louis, Mo.]/ml in phos- 
phate-buffered saline), vortexed for 2 min, and centrifuged at 
13,000 x g for 15 min. Detection of GSA65 antigen in the 
supernatants (1) was performed by using a ProSpecT kit ac­
cording to the instructions of the manufacturer (Alexon- 
Trend). Cyst determination was performed microscopically on 
samples stored in 10% formaldehyde.
For histological analysis, 1 cm of the small intestine collected 
10 cm from the pylorus was fixed in Bouin fixative and dehy­
drated in a graded series of ethanol. Paraffin-embedded sec­
tions of 5 |j.m were rehydrated and stained with hematoxylin 
and eosin.
Intestinal sucrase activity was measured in 5-cm-long sec­
tions of the small intestine which were collected 5 cm below the 
pylorus. The intestinal samples were placed in ice-cold phos- 
phate-buffered saline and flushed with 50 ml of ice-cold dis­
tilled water using a syringe. The segments were then opened 
longitudinally, and the mucosa was collected by scraping with 
a glass microscope slide. Scrapings were stored at —20°C until 
analysis. Intestinal disaccharidase activity was determined as 
previously reported (16). Protein concentrations were deter­
mined using the Bradford assay, and the results are expressed 
as arbitrary units per gram of protein (3).
To determine cell proliferation indices, spleens were placed 
in 2 ml of complete RPMI 1640 medium (10% fetal calf serum, 
1% nonessential amino acids), homogenized through a cell 
strainer (70 |j.m; BD Falcon, Bedford, Mass.), and centrifuged 
at 250 x g for 5 min. The pellets were then rapidly lysed with 
1 ml of sterile distilled water and centrifuged at 250 x g for 5 
min. Cells were resuspended in complete RPMI 1640 medium 
at a concentration of 106 cells/ml before testing cell prolifera­
tion in the presence of the T-cell mitogen concanavalin A 
(ConA) at a concentration of 3 p.g/ml or the B-cell mitogen 
pokeweed mitogen (PWM) at a concentration of 1 p.g/ml (both 
from Sigma). Stimulation in the presence of Giardia antigens 
was also evaluated. These membrane antigens were extracted 
as reported previously (17) and used at a concentration of 10 
|j.g/ml to stimulate the cells.
Spleen cells (105 cells/well) were incubated with complete 
RPMI 1640 medium (control) supplemented with either 
ConA, PWM, or Giardia antigen in a final volume of 200 p.1 of 
medium. After incubation at 37°C for 72 h, the cells were pulse 
labeled with 1.5 p.Ci of [3H]thymidine (Amersham Pharmacia 
Biotech, Dübendorf, Switzerland) for a further 16 h. The cells 
were then harvested on nitrocellulose filters (Packard Bio­
sciences B.V., Groningen, The Netherlands), and the incorpo­
ration of [3H]thymidine was measured by scintillation counting 
(TopCount; Packard Biosciences B.V.). Stimulation indices 
(SI) were determined as the severalfold increase in titrated 
thymidine incorporation in stimulated cells compared to that 
of nonstimulated cells.
Fisher’s two-tailed exact statistical analysis was used to com-
TABLE 1. Infection of gerbils at different time points after 
inoculation with G. intestinalis WB clone C6"
Days 
after 
infection 
with
Giardia
Placebo-treated gerbils Lal-treated gerbils
No. of 
infected 
animals6
Log intensity^ No. of infected animals6 ■intensity
a Gerbils received either Lal or placebo daily from 7 days before inoculation 
with the trophozoites of G. intestinalis WB clone C6 (5 X 105 trophozoites per 
animal). Results are from four independent experiments.
b Number of gerbils with detectable parasites in the small intestine/total num­
ber of gerbils studied. The statistical significance of the infection rate of Lal- 
treated animals compared to that of controls was calculated using Fisher’s exact 
test. P values are shown in parentheses.
' Averages ± standard deviations of the log of parasites per infected gerbil. 
ND, no parasites were detected (<800 trophozoites/cm).
7 10/12 4.63 ± 1.14 3/11 (P = 0.01) 3.81 ± 0.88
14 6/14 5.07 ± 0.93 0/12 (P = 0.02) ND
21 3/6 4.81 ± 1.68 0/6 (P = 0.09) ND
pare infection rates, and the two-tailed t test with equal vari­
ances was used to compare mucosal sucrase activity and cell 
proliferation indices of the two groups (Software InfoStat, 
2004; Grupo InfoStat, FCA, Universidad Nacional de Cor­
doba, Cordoba, Argentina).
As shown in Table 1, there was a peak in the Giardia infec­
tion rate 7 days postinoculation. At this time point, 10 of the 12 
gerbils (83%) in the placebo group and 3 out of 11 gerbils in 
the Lal-treated group had trophozoites in their small intestine 
(P = 0.01). By day 14, the infection was resolved in the Lal- 
treated group, but 6 out of 14 gerbils in the placebo group were 
still infected (Table 1) (P = 0.02). Of these gerbils, three were 
still infected 21 days after inoculation. Although probiotic 
treatment reduced the infection rate, it had no significant effect 
on the intensity of infection (Table 1).
Fecal shedding of GSA65 antigen followed different kinetics 
from that of live trophozoites in the small intestine. In the 
placebo group, the number of GSA65-positive gerbils progres­
sively increased from day 7 to day 21 -posX-Giardia inoculation 
(Fig. 1). In contrast, the single gerbil positive for GSA65 an­
tigen in the Lal-treated group at day 14 was no longer positive 
at day 21 postinoculation (Fig. 1).
G. intestinalis infection in gerbils has a profound effect on 
the structure and function of the intestinal mucosa (Fig. 2). 
Villus shortening and hypercellularity of the lamina propria 
due to increased numbers of mononuclear, polymorphonu­
clear, and eosinophilic cells were observed in control animals. 
In contrast, no morphological damage of the gut mucosa was 
observed in Lal-treated animals. These findings correlated 
well with the difference in mucosal sucrase activity observed in 
the two groups. While the intestines of Lal-treated animals 
maintained an enzymatic activity of approximately 200 arbi­
trary units/g of protein throughout the study, the intestines of 
control animals had decreasing enzymatic activity over time 
(Fig. 3). Differences between the two groups were statistically 
significant at both 14 and 21 days postinoculation (P < 0.05).
No differences in spleen cell proliferation were observed 
between the two treatment groups 7 days after inoculation with 
Giardia trophozoites (data not shown). However, at day 14, 
splenocytes of Lal-treated animals showed a greater response 
to ConA (placebo group SI, 7.8 ± 2.2; Lal-treated group SI, 
22.8 ± 11.6 [P = 0.09]), to PWM, and to Giardia antigen
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FIG. 1. Shedding of fecal GSA65 antigen. Gerbils received either 
Lal (■) or placebo (O) daily from 7 days before inoculation with the 
trophozoites of G. intestinalis WB clone C6 (5 x 105 trophozoites per 
animal). Values represent the ratio between GSA65-positive (GSA65 
+ ) gerbils and the total number of gerbils at various times after 
Giardia infection. The number of animals per group was 18, 12, and 5 
at 7, 14, and 21 days post-Giardia infection, respectively.
(placebo group SI, 1.2 ± 0.2; Lal-treated group SI, 3.7 ± 0.8 
[P = 0.006]) than those of control animals. At 21 days post- 
Giardia infection, a significantly greater response to Giardia 
antigen (placebo group SI, 0.9 ± 0.2; Lal-treated group SI, 3.6
FIG. 3. Intestinal sucrase activity. Gerbils received either Lal or 
placebo daily from 7 days before inoculation with the trophozoites of 
G. intestinalis WB clone C6 (5 x 105 trophozoites per animal). Values 
(arbitrary units [AU] per gram of protein) represent averages from six 
gerbils. Error bars indicate standard deviations. Differences between 
Lal and placebo groups are statistically significant (P = 0.05 and P = 
0.009 at 14 and 21 days, respectively).
± 0.9 [P = 0.007]) and to the B-cell mitogen PWM (placebo 
group SI, 2.1 ± 0.6; Lal-treated group SI, 3.6 ± 0.6 [P = 0.03]) 
was observed, but there was no longer a difference in the 
cellular response to ConA between the two groups (data not 
shown). Research on the efficacy of probiotic bacteria against 
FIG. 2. Histological sections of small intestine. Gerbils received either Lal (A) or placebo (B) daily from 7 days before inoculation with the 
trophozoites of G. intestinalis WB clone C6 (5 x 105 trophozoites per animal). Intestinal segments were collected 7 days post-Giardia infection. 
Sections were stained with hematoxylin and eosin and observed at X100 original magnification. (C) Further magnification of the intestine from 
a control animal. Arrows indicate the presence of trophozoites.
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intestinal infections has focused primarily on protection 
against bacterial pathogens. The present in vivo study consol­
idates recent reports describing the capacity of some lactoba­
cilli of human and canine origin to antagonize Giardia infec­
tion which interferes with the growth and cell cycle of G. 
intestinalis in vitro (36). Mongolian gerbils (Mariones unguícu­
la tus) are a good animal model for studying Giardia infection 
with strains of human origin (3, 4, 11). Their susceptibility to 
giardiasis has been attributed to a deficient antibody response 
to specific Giardia antigens (34). We have observed that gerbils 
are readily infected with trophozoites administered by gavage 
and begin to eliminate cysts in their feces 1 week after inocu­
lation (data not shown). As a consequence of this infection, the 
animals have reduced disaccharidase activity in their intestinal 
mucosa.
The presence of viable trophozoites in the small intestine is 
a recognized marker of Giardia infection (37, 42). We found 
that administration of L. johnsonii Lal dramatically reduces 
the proportion of gerbils with active trophozoites in the gut 
and leads to resolution of infection within 14 days. In contrast, 
viable trophozoites were consistently observed in the intestines 
of the placebo group at all the time points studied (Table 1). 
Furthermore, we have found a time-dependent increase in the 
proportion of GSA65-positive gerbils in this group (Fig. 1). 
Since GSA65 antigen is present on both trophozoites and cysts 
(38), it is important that the increased proportion of GSA65- 
positive gerbils with time may reflect changes in the numbers 
of both trophozoites and cysts reaching the distal small intes­
tine. Certainly, differences in the kinetics of both GSA65 shed­
ding and trophozoite load in the small intestine are related to 
the distribution of trophozoites and cysts along the orad- 
caudad axis (29).
Progression of Giardia infection in gerbils correlates with a 
progressive impairment in intestinal sucrase activity (3), which 
may account for the diminished nutrient absorption and failure 
to thrive associated with giardiasis (11, 19). However, admin­
istration of L. johnsonii Lal protects against the impaired 
sucrase activity and the histological changes found in infected 
animals. (Fig. 2). It is noteworthy that cysts were eliminated in 
only a few of the gerbils in the placebo group (data not shown). 
This is an important observation because cyst production is the 
only means by which the parasite is known to spread. This 
observation is also in agreement with previous studies in vitro 
which have demonstrated that extracellular factors from Lal 
arrest G. intestinalis in the G, phase of the cell cycle (36). 
According to Bernander et al. (6), only trophozoites in G2 
phase progress to the cyst form.
The protective effect of probiotics against intestinal patho­
gens has been ascribed to many factors including antagonism 
by extracellular factors (8, 15, 31), interference with pathogen- 
enterocyte interactions (7, 9), and modulation of the immune 
response (5, 23, 39). Not only innate defense mechanisms but 
both acquired humoral and cell-mediated immune responses 
protect against Giardia infection (2, 18, 20, 27, 28, 42). Here, 
we suggest that Lal treatment reinforces the immune response 
against Giardia in inoculated gerbils. More specifically, we 
show an increased splenocyte response to a T-cell mitogen and 
to Giardia antigens at 14 days postinfection and an increased 
response to a B-cell mitogen and to Giardia antigens at 21 days 
postinfection. Even though selection of trophozoites bearing 
different variant surface proteins in control and Lal-treated 
groups could not be ruled out (35), our results suggest a prim­
ing of the immune system by Lal that leads to clearance of 
both trophozoites and Giardia antigens from the intestines 
(Table 1 and Fig. 1). It is possible that this reflects the devel­
opment of a memory response following probiotic administra­
tion.
Although the mechanisms underlying the virulence of G. 
intestinalis remain poorly understood, both direct interaction 
with enterocytes and secretion of soluble mediators are 
thought to contribute to the pathogenesis (14). The immune 
response of the host and inflammatory status of the intestinal 
mucosa are also key determinants (41). It is therefore inter­
esting that a lower cellular infiltration was observed in the 
intestinal villi of Lal-treated animals than that of controls (Fig. 
2). This result indicates the absence of inflammatory processes 
in the intestine of Lal-treated gerbils.
In the present study, it is unlikely that metabolic products in 
the bacterial suspensions contribute to the protective effects 
observed. Although lactic acid is the main product of Lal 
metabolism, only traces of this organic acid were detected in 
the bacterial suspensions administered (data not shown). Thus, 
the antigiardial effect of L. johnsonii Lal in vivo is probably 
due to the production of inhibitory substances in situ and/or to 
the modulation of the immune response of the host. Certainly, 
previously published results have shown that L. johnsonii Lal 
mediates its anti-Giardia effect through the production of sol­
uble mediators (36) and that it is able to modulate the immune 
response (10, 32, 39).
To summarize, we report for the first time an in vivo effect 
of a probiotic lactobacillus against G. intestinalis. Our results 
provide scientific evidence that the applications of probiotic 
organisms can be extended to include alternative strategies in 
the prevention of a widespread parasitic infection.
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